The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Somatotroph Hyperplasia
Open accessAbstract
A 21-yr-old woman with Turner's syndrome presented with signs and symptoms of acromegaly. The serum growth hormone (GH) (95+/-9.4 ng/ml; mean+/-SEM) and somatomedin C (11 U/ml) levels were elevated, and an increase in GH levels after glucose instead of normal suppression, increase after thyrotropin-releasing hormone (TRH) administration instead of no change, and decrease after dopamine administration instead of stimulation were observed. The pituitary fossa volume was greater than normal (1,440 mm(3)) and the presence of a pituitary tumor was assumed. After tissue removal at transsphenoidal surgery, histological study revealed somatotroph hyperplasia rather than a discrete adenoma. Postoperatively, she remained clinically acromegalic and continued to show increased GH and somatomedin levels. A search was made for ectopic source of a growth hormone-releasing factor (GRF). Computer tomographic scan revealed a 5-cm Diam tumor in the tail of the pancreas. Following removal of this tumor, serum GH fell from 70 to 3 ng/ml over 2 h, and remained low for the subsequent 5 mo. Serum somatomedin C levels fell from 7.2 to normal by 6 wk postoperatively. There were no longer paradoxical GH responses to glucose, TRH, and dopamine. Both the medium that held the tumor cells at surgery and extracts of the tumor contained a peptide with GRF activity. The GRF contained in the tumor extract coeluted on Sephadex G-50 chromatography with rat hypothalamic GH-releasing activity. Stimulation of GH from rat somatotrophs in vitro was achieved at the nanomolar range, using the tumor extract. The patient's course demonstrates the importance of careful interpretation of pituitary histology. Elevated serum GH and somatomedin C levels in a patient with an enlarged sella turcica and the characteristic responses seen in acromegaly to TRH, dopamine, and glucose do not occur exclusively in patients with discrete pituitary tumors and acromegaly. This condition can also occur with somatotroph hyperplasia and then revert to normal after removal of the GRF source. Thus, in patients with acromegaly a consideration of ectopic GRF secretion should be made, and therefore, careful pituitary histology is mandatory. Consideration for chest and abdominal computer tomographic scans before pituitary surgery, in spite of their low yield, may be justified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., & Guillemin, R. (1973) · Science · doi:10.1126/science.179.4068.77 · Cited by 3,532
Self-citationFurlanetto, R. W., Underwood, L. E., Van Wyk, J. J., & D'Ercole, A. J. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108816 · Cited by 850
Culture of Enzymatically Dispersed Anterior Pituitary Cells: Functional Validation of a Method
VALE, W., GRANT, G., AMOSS, M., BLACKWELL, R., & GUILLEMIN, R. (1972) · Endocrinology · doi:10.1210/endo-91-2-562 · Cited by 550
Self-citationNEURON-SPECIFIC ENOLASE IS PRODUCED BY NEUROENDOCRINE TUMOURS
Tapia, F. J., Barbosa, A. J. A., Marangos, P. J., Polak, J. M., Bloom, S. R., Dermody, C., & Pearse, A. G. E. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92682-9 · Cited by 458
FAMILIAL MULTIPLE ENDOCRINE ADENOMA-PEPTIC ULCER COMPLEX
BALLARD, H. S., FRAME, B., & HARTSOCK, R. J. (1964) · Medicine · doi:10.1097/00005792-196407000-00003 · Cited by 439
KRULICH, L., DHARIWAL, A. P. S., & MCCANN, S. M. (1968) · Endocrinology · doi:10.1210/endo-83-4-783 · Cited by 437
The volume of the sella turcica.
Di Chiro, G., & Kb, N. (1962) · PubMed · Cited by 342
Rapid Regression of Pituitary Prolactinomas during Bromocriptine Treatment*
THORNER, M. O., MARTIN, W. H., ROGOL, A. D., MORRIS, J. L., PERRYMAN, R. L., CONWAY, B. P., HOWARDS, S. S., WOLFMAN, M. G., & MACLEOD, R. M. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-3-438 · Cited by 253
Self-citationStimulation of Pituitary Growth Hormone Release by a Hypothalamic Extractin Vitro1
Deuben, R. R., & Meites, J. (1964) · Endocrinology · doi:10.1210/endo-74-3-408 · Cited by 141
Cited by
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253
Melmed, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062453 · Cited by 1,160
HO, K. Y., EVANS, W. S., BLIZZARD, R. M., VELDHUIS, J. D., MERRIAM, G. R., SAMOJLIK, E., FURLANETTO, R., ROGOL, A. D., KAISER, D. L., & THORNER, M. O. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-51 · Cited by 921
Acromegaly pathogenesis and treatment
Melmed, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39375 · Cited by 687
Pituitary-Tumor Endocrinopathies
Melmed, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1810772 · Cited by 604
Clonal Origin of Pituitary Adenomas*
HERMAN, V., FAGIN, J., GONSKY, R., KOVACS, K., & MELMED, S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1427 · Cited by 560
Self-citationInternational Union of Pharmacology. XXXV. The Glucagon Receptor Family
Mayo, K. E., Miller, L. J., Bataille, D., Dalle, S., Göke, B., Thorens, B., & Drucker, D. J. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.6 · Cited by 506
Molecular basis of the little mouse phenotype and Implications for cell type-specific growth
Lin, S.-C., Lin, C. R., Gukovsky, I., Lusis, A. J., Sawchenko, P. E., & Rosenfeld, M. G. (1993) · Nature · doi:10.1038/364208a0 · Cited by 474
Mechanisms for pituitary tumorigenesis: the plastic pituitary
Melmed, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320401 · Cited by 456
Melmed, S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004053221405 · Cited by 438
The pathogenesis of pituitary tumours
Asa, S. L., & Ezzat, S. (2002) · Nature Reviews Cancer · doi:10.1038/nrc926 · Cited by 435
Godfrey, P., Rahal, J. O., Beamer, W. G., Copeland, N. G., Jenkins, N. A., & Mayo, K. E. (1993) · Nature Genetics · doi:10.1038/ng0793-227 · Cited by 397
The Cytogenesis and Pathogenesis of Pituitary Adenomas*
Asa, S. L., & Ezzat, S. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0350 · Cited by 388
Characterization of rat hypothalamic growth hormone-releasing factor
Spiess, J., Rivier, J., & Vale, W. (1983) · Nature · doi:10.1038/303532a0 · Cited by 371
Self-citationGrowth hormone-releasing factor stimulates proliferation of somatotrophs in vitro.
Billestrup, N., Swanson, L. W., & Vale, W. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.6854 · Cited by 325
Self-citationLin, C., Lin, S.-C., Chang, C.-P., & Rosenfeld, M. G. (1992) · Nature · doi:10.1038/360765a0 · Cited by 325
Clinical Biology of the Pituitary Adenoma
Melmed, S., Kaiser, U. B., Lopes, M. B., Bertherat, J., Syro, L. V., Raverot, G., Reincke, M., Johannsson, G., Beckers, A., Fleseriu, M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac010 · Cited by 321
Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor
Barinaga, M., Yamonoto, G., Rivier, C., Vale, W., Evans, R., & Rosenfeld, M. G. (1983) · Nature · doi:10.1038/306084a0 · Cited by 308
Self-citationSomatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant
Struthers, R. S., Vale, W. W., Arias, C., Sawchenko, P. E., & Montminy, M. R. (1991) · Nature · doi:10.1038/350622a0 · Cited by 301
Self-citationThe clinical investigator: bewitched, bothered, and bewildered--but still beloved.
Goldstein, J. L., & Brown, M. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119470 · Cited by 297
EVANS, W. S., SOLLENBERGER, M. J., BOOTH, R. A., ROGOL, A. D., URBAN, R. J., CARLSEN, E. C., JOHNSON, M. L., & VELDHUIS, J. D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-81 · Cited by 285
Self-citationSANO, T., ASA, S. L., & KOVACS, K. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-3-357 · Cited by 268
Self-citationThe Pathogenesis of Pituitary Tumors
Asa, S. L., & Ezzat, S. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092259 · Cited by 263
Ross, D. A., & Wilson, C. B. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.6.0854 · Cited by 260
THORNER, M. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91563-5 · Cited by 260
Self-citationHammer, R. E., Brinster, R. L., Rosenfeld, M. G., Evans, R. M., & Mayo, K. E. (1985) · Nature · doi:10.1038/315413a0 · Cited by 256
Prolactin in Human Reproduction
Molitch, M. E. (2009) · Yen & Jaffe's Reproductive Endocrinology · doi:10.1016/b978-1-4160-4907-4.00003-6 · Cited by 31
Metadata
- Authors
- Thorner, M. O., Perryman, R. L., Cronin, M. J., Rogol, A. D., Draznin, M., Johanson, A., Vale, W., Horvath, E., & Kovacs, K.
- Venue
- Journal of Clinical Investigation
- Published
- 1982-11-01
- Volume
- 70
- Issue
- 5
- Pages
- 965-977
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1941230576
- Cited by
- 393
- References
- 17
- FWCI
- 24.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.